Noa Givon Schaham, Inbal Elbo-Golan, Zvi Buckman, S. Sternberg, D. Rand
{"title":"The feasibility of TECH: Tablet Enhancement of Cognition and Health, a novel cognitive intervention for people with Mild Cognitive Impairment","authors":"Noa Givon Schaham, Inbal Elbo-Golan, Zvi Buckman, S. Sternberg, D. Rand","doi":"10.1109/ICVR46560.2019.8994696","DOIUrl":null,"url":null,"abstract":"This paper presents a novel cognitive intervention utilizing touchscreen tablet applications for self-training: TECH-’Tablet Enhancement of Cognition and Health’ and examined its feasibility for older adults with Mild Cognitive Impairment (MCI). A single-blind randomized controlled trial was conducted and participants were allocated to TECH (experimental) or control group. This paper focuses only on the TECH group. Twenty-eight community-dwelling older adults with MCI (age range 65–87) participated in the TECH groups. Feasibility (adherence and satisfaction from the program) was high. Data collection is still ongoing to establish the effectiveness of TECH for people with MCI.","PeriodicalId":179905,"journal":{"name":"2019 International Conference on Virtual Rehabilitation (ICVR)","volume":"107 Pt 2 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"2019 International Conference on Virtual Rehabilitation (ICVR)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1109/ICVR46560.2019.8994696","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
This paper presents a novel cognitive intervention utilizing touchscreen tablet applications for self-training: TECH-’Tablet Enhancement of Cognition and Health’ and examined its feasibility for older adults with Mild Cognitive Impairment (MCI). A single-blind randomized controlled trial was conducted and participants were allocated to TECH (experimental) or control group. This paper focuses only on the TECH group. Twenty-eight community-dwelling older adults with MCI (age range 65–87) participated in the TECH groups. Feasibility (adherence and satisfaction from the program) was high. Data collection is still ongoing to establish the effectiveness of TECH for people with MCI.